HIVR4P 2016: The Long Tail Problem -- Injectable PrEP Trial To Be Extended Due to Drug Persistence
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Monday, 14 November 2016 00:00
- Written by Gus Cairns
A study presented at last month’s HIV Research for Prevention (HIVR4P) conference in Chicago shows that in a minority of people who were given the experimental injectable drug cabotegravir as HIV pre-exposure prophylaxis (PrEP), the drug was still measurable in their body a full year after their last injection.
IDWeek 2016: HIV+ Men and Men on PrEP in Boston See Large Increase in Sexually Transmitted Infections
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Tuesday, 01 November 2016 00:00
- Written by Liz Highleyman
Rates of gonorrhea, syphilis, and chlamydia have risen steeply at Fenway Health in Boston since 2011, according to presentation last week at IDWeek in New Orleans. Being HIV-positive and using pre-exposure prophylaxis (PrEP) to prevent HIV were associated with higher risk of getting-sexually transmitted infections (STIs), but more frequent STI testing and treatment could potentially help reduce the numbers.
IDWeek 2016: Rapid Emergence of Drug-Resistant Gonorrhea Seen in Ohio
- Details
- Category: Gonorrhea
- Published on Tuesday, 01 November 2016 00:00
- Written by Liz Highleyman
Routine surveillance in southern Ohio has detected a steep increase in gonorrhea showing resistance to ciprofloxacin or reduced susceptibility to azithromycin, according to a presentation at IDWeek last week in New Orleans. Azithromycin is one of the 2 drugs in the sole recommended gonorrhea treatment regimen in the U.S., but no resistance to ceftriaxone, the other drug in that regimen, was seen.
HIVR4P: New HIV Prevention Tools Will Need Marketing and Effective Health Services to Expand Reach
- Details
- Category: HIV Prevention
- Published on Tuesday, 01 November 2016 00:00
- Written by Roger Pebody
There is a naivety among many HIV prevention researchers and advocates about the steps needed to introduce and implement new HIV prevention technologies such as oral pre-exposure prophylaxis (PrEP), vaginal rings, and vaccines, according to speakers at the HIV Research for Prevention (HIVR4P 2016) conference in Chicago last month. Developing an effective prevention method is the easy part, they suggested -- ensuring that the product reaches end users who need them can be more challenging.
IDWeek 2016: Electronic Health Records Can Help Select Candidates for HIV PrEP
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Friday, 28 October 2016 00:00
- Written by Liz Highleyman
A machine learning algorithm used to analyze electronic health records (EHRs) identified high-risk individuals who could potentially benefit from HIV pre-exposure prophylaxis (PrEP), according to a report presented this week at IDWeek 2016 in New Orleans. Out of 800,000 patients in a large EHR database, more that 8000 were found to be potential PrEP candidates.
More Articles...
- IDWeek 2016: Only a Small Proportion of HIV+ Gay Men Receive Anal Cancer Screening
- HIVR4P 2016: Some Americans Who Need PrEP the Most Face the Greatest Barriers
- HIVR4P 2016: PrEP Knowledge and Use Increases in San Francisco, 12,500 People Now on PrEP
- HIVR4P 2016: Huge Diversity in HIV Vaccine Research Discussed at Prevention Conference
- HIVR4P 2016: Rings, Films or Inserts? Prevention Products Need to Make Sense in Women's Lives
- HIVR4P 2016: New Microbicide Enema Achieves High Levels of Drug in Rectal Tissues in Monkeys
- HIVR4P 2016: Vaginal and Rectal Bacteria May Influence HIV Transmission and Microbicide Efficacy
- HIVR4P 2016: Policymakers' Inaction is Leading People to Take "PrEP in the Wild"
- HIVR4P 2016: More Viral Suppression Needed to Reduce HIV Infections Among Gay Men
- HIVR4P 2016: Second Case Report of PrEP Failure Due to Drug-Resistant Virus
- HIVR4P 2016: Anal Sex May Transmit 4 in 10 HIV Infections Among High-Risk U.S. Women
Web Design and Development by